InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 06/04/2019 9:00:48 AM

Tuesday, June 04, 2019 9:00:48 AM

Post# of 13
News: $PTI Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis

BOSTON , June 4, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing...

Got this from https://marketwirenews.com/news-releases/proteostasis-therapeutics-receives-orphan-drug-designation-in-the-eu-for-pti-428-for-the-treatment-of-cystic-fibrosis-8295600.html